Avoid common mistakes on your manuscript.
Correction to: Cancer Chemotherapy and Pharmacology https://doi.org/10.1007/s00280-023-04630-8
In the original publication, the order of authors have been appeared incorrectly as
Feng Yu1 · Hongjie Huo1 · Qiong Tang1
The correct order should read as below:
Hongjie Huo1 · Yu Feng1 · Qiong Tang1
In addition, we have included funding note to the article as below:
This study was supported by Tianjin Union Medical Center (Grant number 2021YJ020).
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Huo, H., Feng, Y. & Tang, Q. Correction to: Inhibition of proteinase-activated receptor 2 (PAR2) decreased the malignant progression of lung cancer cells and increased the sensitivity to chemotherapy. Cancer Chemother Pharmacol (2024). https://doi.org/10.1007/s00280-024-04646-8
Published:
DOI: https://doi.org/10.1007/s00280-024-04646-8